Mylan N.V. (MYL) , reported its latest earnings figures Monday morning. The global generic and specialty pharmaceuticals company, based in the Netherlands, has seen its stock price in a decline for several years. Let's take a look at the charts to help us focus our attention.
In the daily bar chart of MYL, below, we can see that prices have roughly gone nowhere in the past 12 months. Roughly around the $18 level. We have crossed above and below the 50-day moving average line.
Trading volume has not shown a pattern and the daily On-Balance-Volume (OBV) line has moved up and down with the price action. The Moving Average Convergence Divergence (MACD) oscillator is currently above the zero line after trading around it the past year. A very neutral picture.